ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2,3,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
2,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
4,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4,2,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
4,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
6,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6,4,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
6,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
7,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
8,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
10,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10,3,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
10,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
11,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
12,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
14,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
15,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
15,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
15,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
16,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
16,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
17,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
17,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
18,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
19,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
20,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
21,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
21,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
22,1,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
23,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
24,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
24,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
25,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
25,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
26,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
26,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
27,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
27,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
27,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
27,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
28,3,Pituitary enlargement,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
28,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
29,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
29,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
29,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
30,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
30,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
30,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
30,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
31,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
31,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
32,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
32,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
33,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
33,2,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
34,1,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
35,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
35,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
35,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
35,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
35,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
35,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
36,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
36,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
37,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
38,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
38,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
39,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
39,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
39,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
40,1,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
40,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
40,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
40,4,Peripheral pulse decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
41,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
41,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
42,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
43,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
43,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
43,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
44,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
44,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
44,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
45,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
45,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
45,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
46,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
47,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
48,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
49,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
50,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
50,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
51,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
52,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
53,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
55,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
56,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
57,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
57,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
57,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
57,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
57,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
58,1,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
58,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
59,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
59,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
59,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
59,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
60,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
60,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
60,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
60,4,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
60,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
61,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
63,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
63,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
63,3,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
64,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
64,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
64,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
65,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
65,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
65,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
65,4,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
66,1,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
67,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
68,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
68,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
68,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
69,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
69,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
70,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
70,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
71,2,Headache,Headaches NEC,Headaches,Nerv,N
71,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
71,4,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
72,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
72,2,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
72,3,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
73,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
73,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
73,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
73,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
73,5,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
73,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
73,7,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
73,8,Sciatic nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
74,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
75,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
76,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
76,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
76,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
76,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
77,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
77,2,Dental restoration failure,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
77,3,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
77,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
77,5,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
78,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
79,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
79,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
79,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
79,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
79,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
79,7,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
79,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
80,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
81,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
81,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
82,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
82,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
83,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
83,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
84,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
84,2,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
84,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
85,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
85,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
85,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
85,5,Mastication disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
85,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
86,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
87,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
88,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
88,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
89,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
90,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
90,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
90,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
90,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
90,6,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
90,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
90,8,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
90,9,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
91,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
91,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
92,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
93,1,Carcinoid crisis,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
93,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
94,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
94,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
95,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
96,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
97,1,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
97,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
97,3,Xanthopsia,Visual colour distortions,Vision disorders,Eye,N
98,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
98,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
99,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,2,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
99,3,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
99,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
99,5,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
100,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
100,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
101,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
101,2,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
101,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
101,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
101,5,Visual field defect,Visual field disorders,Vision disorders,Eye,N
101,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
102,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
103,1,Cholangitis chronic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
103,2,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
103,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
103,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
103,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
103,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
103,7,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
103,8,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
104,1,Carcinoid syndrome,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
104,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
104,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
105,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
105,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
106,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
106,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
107,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
107,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
107,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
107,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
107,5,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
108,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
108,2,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
108,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
108,4,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
108,5,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
108,6,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
108,7,Omentectomy,Abdominal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
108,8,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
109,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
109,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
109,3,Diastolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
109,4,Headache,Headaches NEC,Headaches,Nerv,N
109,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
109,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
109,7,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
109,8,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
109,9,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
109,10,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
109,11,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
109,12,Obstructive sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
109,13,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
109,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
109,15,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
109,16,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,17,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
110,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
110,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
110,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
110,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
111,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
111,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
111,3,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
112,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
113,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
113,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
113,3,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
113,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
113,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
113,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
114,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
114,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
114,3,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
114,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
114,5,Hypovitaminosis,Vitamin deficiencies NEC,Vitamin related disorders,Metab,N
114,6,Injection site granuloma,Injection site reactions,Administration site reactions,Genrl,N
114,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
114,8,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
114,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
114,10,Mineral deficiency,Mineral related disorders NEC,Iron and trace metal metabolism disorders,Metab,N
114,11,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
114,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
114,13,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
114,14,Thyroid mass,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
114,15,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
115,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
115,2,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
115,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
115,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
115,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
115,6,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
115,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
115,8,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
115,9,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
115,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
115,11,Tumour marker increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
115,12,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
115,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
116,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
116,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
117,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
117,2,Carcinoid heart disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,Y
117,3,Carcinoid syndrome,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
117,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
117,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
117,6,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
117,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
117,8,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
117,9,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
117,10,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
117,11,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
118,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
118,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
118,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
118,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
118,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
119,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
119,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
119,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
119,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
119,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
119,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
119,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
120,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
120,3,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
120,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
120,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
120,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
120,7,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
120,8,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
120,9,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
120,10,Migraine,Migraine headaches,Headaches,Nerv,N
120,11,Pancreatic failure,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
120,12,Stent placement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
120,13,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
120,14,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
121,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
121,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
122,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
122,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
123,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
123,2,Lack of injection site rotation,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
124,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
124,2,Carcinoid heart disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
124,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
124,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
124,5,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
124,6,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
124,7,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
124,8,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
124,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
125,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
125,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
126,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
127,1,Carcinoid heart disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
127,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
127,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
127,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
128,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
128,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
128,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
128,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
128,5,Hepatic embolisation,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
128,6,Hepatic embolisation,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
129,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
129,2,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
130,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
130,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
131,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
131,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
132,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
132,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
132,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
132,4,Paracentesis,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
132,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
132,6,Thoracic cavity drainage,Chest wall and mediastinal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
133,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
134,1,Aortic dilatation,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
134,2,Aortic valve incompetence,Aortic valvular disorders,Cardiac valve disorders,Card,N
134,3,Aortic valve stenosis,Aortic valvular disorders,Cardiac valve disorders,Card,N
134,4,Aortic valve thickening,Aortic valvular disorders,Cardiac valve disorders,Card,N
134,5,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
134,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
134,7,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
134,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
134,9,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
134,10,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
134,11,Tricuspid valve thickening,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
135,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
135,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
135,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
135,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
135,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
135,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
137,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
137,2,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
137,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
138,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
138,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
139,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
139,2,Hepatic artery embolism,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
139,3,Hepatic neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
140,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
141,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
141,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
142,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
143,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
143,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
143,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
143,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
143,5,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
143,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
143,7,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
143,8,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
143,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
143,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
143,11,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
144,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
145,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
146,1,Migraine,Migraine headaches,Headaches,Nerv,N
147,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
147,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
147,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
148,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
148,2,Headache,Headaches NEC,Headaches,Nerv,N
148,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
149,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
149,2,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
150,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
150,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
151,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
151,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
152,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
152,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
152,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
152,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
152,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
153,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
153,2,Heart valve operation,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
153,3,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
153,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
153,5,Postoperative renal failure,Urinary tract procedural complications,Procedural related injuries and complications NEC,Inj&P,N
154,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
154,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
154,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
154,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
155,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
155,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
155,3,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
155,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
155,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
156,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
156,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
156,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
157,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
158,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
159,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
160,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
160,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
161,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
162,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
162,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
162,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
162,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
162,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
162,6,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
163,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
163,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
163,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
164,1,Blood chromogranin A increased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
164,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
164,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
164,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
164,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
165,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
165,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
166,1,Blood chromogranin A increased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
166,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
166,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
167,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
168,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
169,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
169,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
169,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
169,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
170,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
170,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
171,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
171,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
171,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
171,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
171,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
171,7,Headache,Headaches NEC,Headaches,Nerv,N
171,8,Vaccination site bruising,Vaccination site reactions,Administration site reactions,Genrl,N
172,1,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
172,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
173,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
173,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
174,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
175,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
175,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
175,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
175,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
176,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
176,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
176,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
176,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
176,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
176,6,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
177,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
177,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
177,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
177,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
178,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
178,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
179,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
180,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
181,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
182,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
183,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
183,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
184,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
184,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
185,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
185,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
186,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
187,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
188,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
188,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
188,3,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
189,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
189,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
189,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
190,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
191,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
191,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
191,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
191,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
191,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
191,6,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
191,7,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,Y
191,8,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
191,9,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
192,1,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
192,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
192,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
193,1,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
193,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
193,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
194,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
194,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
195,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
195,2,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
195,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
195,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
195,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
195,6,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
195,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
196,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
196,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
196,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
196,4,Foot operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
196,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,6,Surgical failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
198,1,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
199,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
199,2,Headache,Headaches NEC,Headaches,Nerv,N
200,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
200,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
200,3,Headache,Headaches NEC,Headaches,Nerv,N
200,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
200,5,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
200,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
202,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
202,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
202,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
202,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
202,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
203,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
203,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
204,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
204,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
204,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
204,4,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
204,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
204,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
205,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
206,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
207,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
207,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
208,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
209,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
209,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
210,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
210,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
210,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
211,1,Testicular seminoma (pure),Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
212,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
212,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
213,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
213,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
213,3,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
214,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
214,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
215,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
216,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
217,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
217,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,1,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
218,2,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
219,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
220,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
221,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
221,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
222,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
222,2,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
222,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
223,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
223,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
223,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
224,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
224,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
224,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
225,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
226,1,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
226,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
226,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
226,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
226,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
227,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
227,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
228,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
228,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
229,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
229,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
229,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
229,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
229,5,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
230,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
230,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
230,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
230,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
231,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
231,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
231,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
232,1,White coat hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
233,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
233,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
233,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
234,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
235,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
235,2,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
235,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
235,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
236,1,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
237,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
237,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
238,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
238,2,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
239,1,Pancreatic failure,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
240,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
240,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
241,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
241,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
241,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
241,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
242,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
242,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
242,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
243,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
243,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
244,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
245,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
245,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
245,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
246,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
247,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
248,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
249,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
250,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
250,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
251,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
252,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
253,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
253,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
253,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
254,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
254,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
255,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
255,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
255,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
256,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
256,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
256,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
256,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
256,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
256,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
258,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
258,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
258,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
259,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
259,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
260,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
260,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
261,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
261,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
261,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
261,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
261,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
262,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
263,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
264,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
265,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
265,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
266,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
266,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
267,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
268,1,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
269,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
269,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
269,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
270,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
270,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
270,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
271,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
271,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
271,3,Headache,Headaches NEC,Headaches,Nerv,N
272,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
272,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
273,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
274,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
275,1,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
276,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
276,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
276,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
276,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
276,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
277,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
277,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
278,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
278,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
278,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
278,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
279,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
279,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
279,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
280,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
281,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
281,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
281,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
281,4,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
281,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
282,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
282,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
282,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
282,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
283,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
284,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
285,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
285,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
286,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
287,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
287,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
288,1,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
288,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
288,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
288,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
288,5,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
289,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
289,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
289,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
290,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
290,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
291,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
291,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
291,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
291,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
292,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
292,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
293,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
294,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
294,2,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
294,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
294,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
295,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
295,2,Headache,Headaches NEC,Headaches,Nerv,N
296,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
296,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
296,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
296,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
297,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
297,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
298,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
298,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
299,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
299,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
299,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
300,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
300,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
300,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
300,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
300,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
300,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
300,7,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
300,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
300,9,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
300,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,11,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
300,12,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
300,13,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
300,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
301,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
301,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
301,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
301,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
301,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
301,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
301,7,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
301,8,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
301,9,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
301,10,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
301,11,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
301,12,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
301,13,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
301,14,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
301,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
301,16,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
301,17,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
301,18,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
302,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
302,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
303,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
303,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
304,1,Hepatic neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
304,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
305,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
306,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
306,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
307,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
307,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
308,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
308,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
309,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
309,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
309,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
309,4,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
310,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
311,1,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
312,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
312,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
312,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
313,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
313,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
313,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
313,5,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
313,6,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
313,7,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
313,8,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
313,9,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
313,10,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
313,11,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
313,12,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
313,13,Headache,Headaches NEC,Headaches,Nerv,N
313,14,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
313,15,Injection site nerve damage,Injection site reactions,Administration site reactions,Genrl,N
313,16,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
313,17,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
313,18,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
313,19,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
313,20,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
313,21,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,22,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
313,23,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
313,24,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
314,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
314,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
315,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
315,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
315,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
315,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
316,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
317,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
318,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
319,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
319,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
319,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
319,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
319,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
319,6,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
319,7,Haemorrhoidal haemorrhage,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
319,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
319,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
320,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
320,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
320,3,Patient dissatisfaction with treatment,Social issues NEC,Lifestyle issues,SocCi,N
321,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
321,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
321,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
321,4,Headache,Headaches NEC,Headaches,Nerv,N
321,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
322,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
322,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
322,3,Device issue,Device issues NEC,Device issues,Prod,N
322,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
322,5,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
322,6,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
322,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
322,8,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
322,9,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
322,10,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
323,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
323,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
323,3,Carbohydrate intolerance,Sugar intolerance (excl glucose intolerance),Food intolerance syndromes,Metab,N
323,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
323,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
323,6,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
323,7,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
323,8,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
323,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
324,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
324,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
324,3,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
324,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
324,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
325,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
325,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
325,3,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
325,4,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
326,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
327,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
327,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
327,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
327,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
327,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
327,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
327,7,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
327,8,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
327,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
327,10,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
328,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
328,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
328,3,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
328,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
328,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
328,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
329,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
329,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
329,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
329,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
329,5,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
330,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
330,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
330,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
331,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
331,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
331,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
331,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
331,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
332,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
333,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
334,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
334,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
334,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
334,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
334,5,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
335,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
335,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
335,3,Cricopharyngeal dysfunction,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
335,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
335,5,Diverticulum oesophageal,Diverticula,Diverticular disorders,Gastr,N
335,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
335,7,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
335,8,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
335,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
335,10,Pharyngeal pouch,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
335,11,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
335,12,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
336,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
336,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
336,3,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
336,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
336,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
336,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
336,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
336,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
336,9,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
337,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
338,1,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
338,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
338,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
338,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
339,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
339,2,Wrist surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
340,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
340,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
340,3,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
340,4,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
340,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
340,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
340,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
340,8,Small intestine carcinoma,Small intestinal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
340,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
341,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
341,2,Device defective,Device physical property and chemical issues,Device issues,Prod,N
341,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
341,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
341,5,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
341,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
341,7,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
342,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
343,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
343,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
343,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
343,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
343,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
343,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
344,1,Acarodermatitis,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
344,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
344,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
344,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
345,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
346,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
346,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
346,3,Device issue,Device issues NEC,Device issues,Prod,N
346,4,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
346,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
346,6,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
346,7,Headache,Headaches NEC,Headaches,Nerv,N
346,8,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
346,9,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
346,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
346,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
346,12,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
347,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
348,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
348,2,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
348,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
348,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
348,5,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
349,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
349,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
349,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
349,4,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
349,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
349,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
350,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
350,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
350,3,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
350,4,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
350,5,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
350,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
350,7,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
350,8,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
350,9,Varicophlebitis,Varicose veins NEC,Venous varices,Vasc,N
350,10,Varicose ulceration,Varicose veins NEC,Venous varices,Vasc,N
350,11,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
351,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
351,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
351,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
351,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
352,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
352,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
352,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
352,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
352,5,Headache,Headaches NEC,Headaches,Nerv,N
352,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
352,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
353,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
353,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
353,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
353,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
354,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
354,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
354,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
354,4,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
354,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
355,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
355,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
355,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
356,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
356,2,Headache,Headaches NEC,Headaches,Nerv,N
356,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
357,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
357,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
357,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
357,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
357,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
357,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
357,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
357,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
357,9,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
357,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
357,11,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
358,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
359,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
359,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
359,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
360,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
360,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
360,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
360,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
360,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
361,1,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
362,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
362,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
363,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
363,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
363,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
363,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
363,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
363,6,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
363,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
364,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
365,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
365,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
365,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
365,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
366,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
366,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
366,3,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
366,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
366,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
366,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
366,7,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
366,8,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
367,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
367,2,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
367,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
367,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
368,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
368,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
368,3,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
368,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
368,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
368,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
368,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
369,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
369,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
369,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
369,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
369,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
369,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
369,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
369,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
369,9,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
370,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
370,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
371,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
371,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
371,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
372,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
372,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
372,3,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
373,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
373,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
373,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
373,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
373,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
373,6,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
373,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
373,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
374,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
375,1,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
375,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
375,3,Device issue,Device issues NEC,Device issues,Prod,N
375,4,Device leakage,Device issues NEC,Device issues,Prod,N
375,5,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
375,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
375,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
375,8,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
375,9,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
375,10,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
375,11,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
375,12,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
376,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
377,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
377,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
377,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
377,4,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
377,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
378,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
378,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
378,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
378,4,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
379,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
379,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
379,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
379,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
379,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
379,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
379,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
379,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
379,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
380,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
380,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
381,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
381,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
381,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
382,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
382,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
383,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
383,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
384,1,Device leakage,Device issues NEC,Device issues,Prod,N
384,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
384,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
384,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
384,5,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
385,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
386,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
386,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
386,3,Device issue,Device issues NEC,Device issues,Prod,N
386,4,Device leakage,Device issues NEC,Device issues,Prod,N
386,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
386,6,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
386,7,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
386,8,Patient dissatisfaction with device,Social issues NEC,Lifestyle issues,SocCi,N
386,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
386,10,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
387,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
387,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
388,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
388,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
389,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
389,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
389,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
389,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
389,5,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
389,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
389,7,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
389,8,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
389,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
390,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
390,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
391,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
392,1,Device issue,Device issues NEC,Device issues,Prod,N
392,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
392,3,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
393,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
393,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
394,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
394,2,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
394,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
394,4,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
395,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
395,2,C-reactive protein decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
395,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
395,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
395,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
395,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
396,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
396,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
396,3,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
396,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
396,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
396,6,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
396,7,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
397,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
397,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
397,3,Nipple infection,Breast infections,Infections - pathogen unspecified,Infec,N
397,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
398,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
399,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
400,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
400,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
400,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
400,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
401,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
401,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
401,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
402,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
402,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
403,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
403,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
404,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
404,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
405,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
405,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
406,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
406,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
406,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
407,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
407,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
407,3,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
407,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
407,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
407,6,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
408,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
408,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
408,3,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
408,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
408,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
408,6,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
408,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
408,8,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
408,9,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
408,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
408,11,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
408,12,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
408,13,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
409,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
409,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
409,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
409,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
410,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
410,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
411,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
411,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
412,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
412,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
412,3,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
412,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
412,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
412,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
412,7,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
412,8,Gluten sensitivity,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
412,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
412,10,Vitamin B12 decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
412,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
413,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
413,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
413,3,Excessive cerumen production,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
413,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
413,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
413,6,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
413,7,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
413,8,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
413,9,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
413,10,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
413,11,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
413,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
413,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
414,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
414,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
414,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
414,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
414,5,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
414,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
414,7,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
414,8,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
414,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
414,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
414,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
414,12,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
414,13,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
414,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
415,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
415,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
415,3,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
415,4,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
415,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
415,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
415,7,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
415,8,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
415,9,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
415,10,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
415,11,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
415,12,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
415,13,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
416,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
416,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
416,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
416,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
416,5,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
417,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
417,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
417,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
417,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
417,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
418,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
418,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
419,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
419,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
419,3,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
419,4,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
420,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
421,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
421,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
421,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
422,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
422,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
422,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
423,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
424,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
424,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
424,3,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
424,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
424,5,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
424,6,Oxygen saturation abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
424,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
424,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
425,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
425,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
425,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
425,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
425,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
425,6,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
425,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
425,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
425,9,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
426,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
426,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
426,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
426,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
426,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
426,6,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
426,7,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
427,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
427,2,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
427,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
427,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
427,5,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
427,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
427,7,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
427,8,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
427,9,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
427,10,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
427,11,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
427,12,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
428,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
428,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
428,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
428,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
428,5,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
428,6,Sternal fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
428,7,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
429,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
429,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
429,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
429,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
429,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
429,6,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
429,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
430,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
430,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
430,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
430,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
431,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
431,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
431,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
432,1,Aneurysm,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
432,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
432,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
432,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
432,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
433,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
433,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
433,3,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
433,4,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
433,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
433,6,Death,Death and sudden death,Fatal outcomes,Genrl,Y
433,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
433,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
433,9,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
434,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
434,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
434,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
434,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
434,5,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
434,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
434,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
434,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
434,9,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
434,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
434,11,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
434,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
435,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
436,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
436,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
436,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
436,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
437,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
437,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
438,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
438,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
438,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
438,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
438,5,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
439,1,Hospice care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
439,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
440,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
440,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
440,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
440,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
440,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
440,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
440,7,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
441,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
441,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
441,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
441,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
441,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
442,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
443,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
443,2,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
443,3,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
444,1,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
444,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
444,3,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
444,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,5,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
445,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
446,1,Migraine,Migraine headaches,Headaches,Nerv,N
446,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
447,1,Cancer surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
447,2,Device issue,Device issues NEC,Device issues,Prod,N
447,3,Device issue,Device issues NEC,Device issues,Prod,N
447,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
447,5,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
448,1,Headache,Headaches NEC,Headaches,Nerv,N
448,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
449,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
449,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
449,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
449,4,White coat hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
450,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
450,2,Headache,Headaches NEC,Headaches,Nerv,N
451,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
452,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
452,2,Headache,Headaches NEC,Headaches,Nerv,N
452,3,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
452,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
453,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
453,2,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
453,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
453,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
453,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
453,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
453,7,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
454,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
454,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
454,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
454,4,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
454,5,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
454,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
454,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
454,8,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
454,9,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
454,10,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
454,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
454,12,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
454,13,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
454,14,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
454,15,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
455,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
455,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
456,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
456,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
456,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
456,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
456,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
456,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
456,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
456,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
456,9,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
456,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
457,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
457,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
457,3,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
457,4,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
457,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
457,6,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
457,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
458,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
459,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
460,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
460,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
460,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
460,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
461,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
461,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
461,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
461,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
461,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
461,6,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
461,7,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
462,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
462,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
462,3,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
462,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
462,5,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
463,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
464,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
464,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
464,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
465,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
465,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
465,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
465,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
465,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
465,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
465,7,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
466,1,Abdominal operation,Abdominal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
466,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
467,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
467,2,Brain operation,Skull and brain therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
467,3,Headache,Headaches NEC,Headaches,Nerv,N
468,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
468,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
468,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
468,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
468,5,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
468,6,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
468,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
468,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
469,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
469,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
469,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
469,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
469,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
469,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
469,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
469,8,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
469,9,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
469,10,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
470,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
471,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
471,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
471,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
471,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
472,1,Device issue,Device issues NEC,Device issues,Prod,N
472,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
472,3,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
473,1,Hospice care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
473,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
474,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
474,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
475,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
475,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
475,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
475,4,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
475,5,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
475,6,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
475,7,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
476,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
477,1,Device leakage,Device issues NEC,Device issues,Prod,N
477,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
477,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
477,4,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
477,5,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
477,6,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
477,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
477,8,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
477,9,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
478,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
478,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
479,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
480,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
480,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
480,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
481,1,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
481,2,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
481,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
481,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
482,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
482,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
483,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
484,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
484,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
485,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
486,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
487,1,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
488,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
488,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
489,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
489,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
489,3,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
489,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
489,5,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
489,6,Injection site dryness,Injection site reactions,Administration site reactions,Genrl,N
490,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
491,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
491,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
491,3,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
491,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
491,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
491,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
492,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
493,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
493,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
493,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
493,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
493,5,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
494,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
494,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
494,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
494,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
494,5,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
495,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
496,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
496,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
496,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
496,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
496,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
496,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
496,7,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
496,8,Headache,Headaches NEC,Headaches,Nerv,N
497,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
497,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
497,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
497,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
498,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
498,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
498,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
498,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
498,5,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
498,6,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
499,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
499,2,Device leakage,Device issues NEC,Device issues,Prod,N
499,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
499,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
500,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
500,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
500,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
500,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
500,5,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
501,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
501,2,Device material issue,Device physical property and chemical issues,Device issues,Prod,N
501,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
501,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
501,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
501,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
501,7,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
501,8,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
502,1,Device leakage,Device issues NEC,Device issues,Prod,N
502,2,Device use error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
502,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
502,4,Obstruction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
502,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
502,6,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
503,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
503,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
503,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
504,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
504,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
504,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
504,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
504,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
504,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
505,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
505,2,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
506,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
507,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
507,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
508,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
508,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
508,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
508,4,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
508,5,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
509,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
509,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
509,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
509,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
509,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
509,6,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
509,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
510,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
510,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
510,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
510,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
510,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
510,6,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
511,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
511,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
511,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
511,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
511,5,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
511,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
512,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
512,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
512,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
512,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
512,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
512,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
512,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
512,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
512,9,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
513,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
513,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
513,3,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
513,4,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
513,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
513,6,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
514,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
514,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
514,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
515,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
515,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
515,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
516,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
516,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
517,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
517,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
517,3,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
518,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
518,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
518,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
518,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
518,5,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
518,6,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
519,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
519,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
519,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
520,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
521,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
521,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
522,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
523,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
523,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
523,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
523,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
523,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
523,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
523,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
524,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
524,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
524,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
524,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
524,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
525,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
525,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
525,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
525,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
525,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
525,6,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
525,7,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
525,8,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
526,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
526,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
526,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
527,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
527,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
528,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
528,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
528,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
528,4,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
529,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
530,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
530,2,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
530,3,Device issue,Device issues NEC,Device issues,Prod,N
530,4,Device issue,Device issues NEC,Device issues,Prod,N
530,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
530,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
530,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
530,8,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
531,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
532,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
532,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
533,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
533,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
533,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
534,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
534,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
534,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
535,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
535,2,Inadequate diet,Dietary and nutritional issues,Lifestyle issues,SocCi,N
536,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
537,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
537,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
537,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
537,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
537,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
537,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
537,7,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
538,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
538,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
539,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
540,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
541,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
542,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
542,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
542,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
542,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
542,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
542,6,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
542,7,Device issue,Device issues NEC,Device issues,Prod,N
542,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
542,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
542,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
542,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
542,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
542,13,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
542,14,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
542,15,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
542,16,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
542,17,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
542,18,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
542,19,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
542,20,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
542,21,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
542,22,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
542,23,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
543,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
543,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
543,3,Electrocardiogram ST-T segment abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
543,4,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
543,5,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
544,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
544,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
544,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
545,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
545,2,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
545,3,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
545,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
545,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
545,6,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
546,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
546,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
546,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
547,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
547,2,Device safety feature issue,Device issues NEC,Device issues,Prod,N
547,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
548,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
548,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
548,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
548,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
548,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
548,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
549,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
549,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
549,3,Oxygen saturation abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
549,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
549,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
549,6,Spondylolisthesis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
549,7,Walking aid user,Disability issues,Lifestyle issues,SocCi,N
550,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
550,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
551,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
551,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
551,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
552,1,Device issue,Device issues NEC,Device issues,Prod,N
552,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
552,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
552,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
552,5,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
552,6,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
552,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
552,8,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
552,9,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
552,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
552,11,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
552,12,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
552,13,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
553,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
554,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
554,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
554,3,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
555,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
555,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
556,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
557,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
557,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
558,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
558,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
558,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
558,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
559,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
560,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
560,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
560,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
560,4,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
561,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
561,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
561,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
562,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
562,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
563,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
563,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
564,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
564,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
564,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
564,4,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
564,5,Moisture-associated skin damage,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
564,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
564,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
564,8,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
565,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
565,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
565,3,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
566,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
566,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
566,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
566,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
567,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
567,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
567,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
568,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
568,2,Bone neoplasm,Bone neoplasms unspecified malignancy,Skeletal neoplasms malignant and unspecified,Neopl,N
568,3,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
568,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
568,5,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
568,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
568,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
568,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
569,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
570,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
571,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
571,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
571,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
571,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
571,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
571,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
571,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
572,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
573,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
574,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
574,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
574,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
575,1,Faeces soft,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
576,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
576,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
576,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
576,4,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
577,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
577,2,Device use error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
577,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
578,1,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
578,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
578,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
578,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
578,5,Upper respiratory tract congestion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
579,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
579,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
579,3,Lymph node pain,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
579,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
580,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
580,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
580,3,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
580,4,Device issue,Device issues NEC,Device issues,Prod,N
580,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
580,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
580,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
581,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
581,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
581,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
582,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
582,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
583,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
583,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
584,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
584,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
584,3,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
585,1,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
585,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
586,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
587,1,Noninfective gingivitis,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
588,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
588,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
588,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
589,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
590,1,Device leakage,Device issues NEC,Device issues,Prod,N
590,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
590,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
591,1,Headache,Headaches NEC,Headaches,Nerv,N
591,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
591,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
592,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
592,2,Device leakage,Device issues NEC,Device issues,Prod,N
592,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
592,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
592,5,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
593,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
593,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
593,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
593,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
594,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
594,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
594,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
595,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
595,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
595,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
595,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
595,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
596,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
596,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
597,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
597,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
598,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
598,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
598,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
598,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
598,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
598,6,Patient dissatisfaction with device,Social issues NEC,Lifestyle issues,SocCi,N
599,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
600,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
601,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
601,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
602,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
602,2,Headache,Headaches NEC,Headaches,Nerv,N
603,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
604,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
604,2,Device leakage,Device issues NEC,Device issues,Prod,N
604,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
604,4,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
605,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
605,2,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
606,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
606,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
607,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
608,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
608,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
608,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
609,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
610,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
610,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
610,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
611,1,White coat hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
612,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
612,2,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
613,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
613,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
613,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
614,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
614,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
615,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
615,2,Headache,Headaches NEC,Headaches,Nerv,N
615,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
616,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
617,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
618,1,Transurethral prostatectomy,Prostatic therapeutic procedures,Male genital tract therapeutic procedures,Surg,N
619,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
619,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
619,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
619,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
619,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
620,1,Carcinoid crisis,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
620,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
621,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
621,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
621,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
622,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
622,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
622,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
622,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
623,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
623,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
624,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
625,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
625,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
626,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
626,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
626,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
627,1,Acne,Acnes,Skin appendage conditions,Skin,N
627,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
627,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
627,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
627,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
627,6,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
628,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
628,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
628,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
628,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
628,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
628,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
628,7,Vein collapse,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
629,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
629,2,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
629,3,Device leakage,Device issues NEC,Device issues,Prod,N
629,4,Device use error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
629,5,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
629,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
630,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
630,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
630,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
630,4,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
630,5,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
631,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
632,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
632,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
633,1,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
633,2,Sinonasal obstruction,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
634,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
634,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
635,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
635,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
635,3,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
635,4,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
636,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
636,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
637,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
637,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
638,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
638,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
638,3,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
639,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
640,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
641,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
642,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
642,2,Device leakage,Device issues NEC,Device issues,Prod,N
642,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
642,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
643,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
643,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
643,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
643,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
643,5,Headache,Headaches NEC,Headaches,Nerv,N
643,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
644,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
644,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
644,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
644,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
645,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
645,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
646,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
647,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
648,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
649,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
649,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
650,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
650,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
